Cargando…

Medical outcomes of children with neurodevelopmental disorders after SARS-CoV-2 vaccination: A six-month follow-up study

INTRODUCTION: The BNT162b2 (Pfizer–BioNTech) and mRNA-1273 (Moderna) vaccines have been approved for children and adolescents for protecting against SARS-CoV-2 infection. This longitudinal study aimed to compare adverse outcomes after SARS-CoV-2 vaccination in children with neurodevelopmental disord...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Liang-Jen, Tsai, Ching-Shu, Chou, Wen-Jiun, Li, Chia-Jung, Lee, Sheng-Yu, Chen, Yi-Chun, Lin, I-Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225977/ https://www.ncbi.nlm.nih.gov/pubmed/37271705 http://dx.doi.org/10.1016/j.vaccine.2023.05.067

Ejemplares similares

Efficacy of Six Different SARS-CoV-2 Vaccines during a Six-Month Follow-Up and Five COVID-19 Waves in Brazil and Mexico
por: Romero-Ibarguengoitia, Maria Elena, et al.
Publicado: (2023)

Phthalates, Para-Hydroxybenzoic Acids, Bisphenol-A, and Gonadal Hormones’ Effects on Susceptibility to Attention-Deficit/Hyperactivity Disorder
por: Tsai, Ching-Shu, et al.
Publicado: (2020)

Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life
por: Zerbo, Ousseny, et al.
Publicado: (2023)

Effect of Bifidobacterium bifidum on Clinical Characteristics and Gut Microbiota in Attention-Deficit/Hyperactivity Disorder
por: Wang, Liang-Jen, et al.
Publicado: (2022)

Immune profile of healthcare professionals six months after vaccination or exposure to SARS‐CoV‐2 in Angola
por: Sebastião, Cruz S., et al.
Publicado: (2023)

Coordinated cortical thickness alterations across six neurodevelopmental and psychiatric disorders
por: Hettwer, M. D., et al.
Publicado: (2022)

SARS-CoV-2 associated liver injury: a six-month follow-up analysis of liver function recovery
por: Roman, Adina, et al.
Publicado: (2022)

Evaluation of immunogenicity post two doses of inactivated SARS-CoV-2 vaccine, Covaxin after six months
por: Sahay, Rima R., et al.
Publicado: (2022)

Dynamics of SARS-CoV-2 Antibody Responses up to 9 Months Post-Vaccination in Individuals with Previous SARS-CoV-2 Infection Receiving Inactivated Vaccines
por: Wang, Jing, et al.
Publicado: (2023)

Autism and Neurodevelopmental Disorders: The SARS-CoV-2 Pandemic Implications
por: Narzisi, Antonio, et al.
Publicado: (2023)

Effect of a Six-Week Core Conditioning as a Warm-Up Exercise in Physical Education Classes on Physical Fitness, Movement Capability, and Balance in School-Aged Children
por: Chang, Nai-Jen, et al.
Publicado: (2020)

CNVs in neurodevelopmental disorders
por: Lee, Chun-Ting, et al.
Publicado: (2015)

Antibody Response Six Months after SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease
por: Frey, Sarah, et al.
Publicado: (2022)

PATIENTS WITH ASTHMA OR ATOPIC DERMATITIS TAKING BIOLOGIC THERAPIES HAVE REDUCED SARS-COV-2 VACCINE RESPONSE AT SIX MONTHS
por: RUNNSTROM, MARTIN C, et al.
Publicado: (2022)

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
por: Chao, Chiao-Hsuan, et al.
Publicado: (2022)

Six month-follow up of laparoscopic sleeve gastrectomy
por: Keleidari, Behrouz, et al.
Publicado: (2016)

Neurodevelopmental disorders, immunity, and cancer are connected
por: Nussinov, Ruth, et al.
Publicado: (2022)

Relevant SARS-CoV-2 Genome Variation through Six Months of Worldwide Monitoring
por: Hakmaoui, Abdelmalek, et al.
Publicado: (2021)

A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection
por: Tzeng, Tsai-Teng, et al.
Publicado: (2022)

Six-Month Follow-Up of Immune Responses after a Rapid Mass Vaccination against SARS-CoV-2 with BNT162b2 in the District of Schwaz/Austria
por: Bánki, Zoltán, et al.
Publicado: (2022)

Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine
por: Ferrari, Davide, et al.
Publicado: (2021)

Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod
por: Capuano, Rocco, et al.
Publicado: (2022)

Humoral Response to BNT162b2 Vaccine Against SARS-CoV-2 Variants Decays After Six Months
por: Lopera, Tulio J., et al.
Publicado: (2022)

Six months SARS-CoV-2 serology in a cohort of mRNA vaccinated subjects over 90 years old
por: Tomaiuolo, Rossella, et al.
Publicado: (2022)

Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis
por: Hughes, Robert M., et al.
Publicado: (2023)

The “Fortilat” Randomized Clinical Trial Follow-Up: Neurodevelopmental Outcome at 18 Months of Age
por: Peila, Chiara, et al.
Publicado: (2020)

Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: A prospective randomized, single-blind controlled trial
por: Wu, Yung-Tsan, et al.
Publicado: (2017)

Immunogenicity and safety of two-dose SARS-CoV-2 vaccination via different platforms in kidney transplantation recipients
por: Chen, Chien-Chia, et al.
Publicado: (2022)

Peripheral Brain-Derived Neurotrophic Factor and Contactin-1 Levels in Patients with Attention-Deficit/Hyperactivity Disorder
por: Wang, Liang-Jen, et al.
Publicado: (2019)

Cytokine Levels and Neuropsychological Function among Patients with Attention-Deficit/Hyperactivity Disorder and Atopic Diseases
por: Chang, Shung-Jie, et al.
Publicado: (2022)

Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine
por: Ciabattini, Annalisa, et al.
Publicado: (2021)

Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose
por: Canetti, Michal, et al.
Publicado: (2022)

Prediction of Neurodevelopmental Outcomes in SARS-CoV-2 Infections
por: Madaan, Priyanka, et al.
Publicado: (2021)

SARS-CoV-2 Specific Antibody Response and T Cell-Immunity in Immunocompromised Patients up to Six Months Post COVID: A Pilot Study
por: Sjöwall, Johanna, et al.
Publicado: (2022)

Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine
por: Gandolfo, Claudia, et al.
Publicado: (2022)

Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections
por: Taquet, Maxime, et al.
Publicado: (2022)

Humoral Response to mRNA-1273 SARS-CoV-2 Vaccine in Peritoneal Dialysis Patients: Is Boostering After Six Months Adequate?
por: Beilhack, Georg, et al.
Publicado: (2022)

Slower Waning of Anti-SARS-CoV-2 IgG Levels Six Months after the Booster Dose Compared to Primary Vaccination
por: Zember, Sanja, et al.
Publicado: (2022)

The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread
por: Bui, Ngoc-Niem, et al.
Publicado: (2021)

Dynamics of breast milk antibody titer in the six months following SARS-CoV-2 infection
por: Duncombe, Caroline J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_33lnk1clv2kid5ubl449jcfsbl